RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Amgen Inc.

A collection of news and information related to Amgen Inc. published by this site and its partners.

Top Amgen Inc. Articles see all

Displaying items 1-5
  • Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

    NEW YORK/PARIS (Reuters) - A new drug being developed by Sanofi SA and Regeneron Pharmaceuticals Inc significantly cut cholesterol in nine late-stage clinical trials, the companies said on Wednesday, and provided the first glimpse of its potential to prevent heart attacks and strokes.
  • S&P 500 y Nasdaq cierran en alza ante falta de apuro de Fed con tasas

    NUEVA YORK (Reuters) - Los índices bursátiles S&P 500 y Nasdaq cerraron con leves avances el miércoles luego de que la Reserva Federal dio una evaluación más optimista de la economía estadounidense, y ratificó que no hay ningún apuro en subir las tasas de...

    S&P 500, Nasdaq end up as Fed in no rush to raise rates

    S&P 500, Nasdaq end up as Fed in no rush to raise rates
    NEW YORK (Reuters) - The S&P 500 and Nasdaq ended higher on Wednesday after the Federal Reserve gave a rosier assessment of the U.S. economy while reaffirming that it is in no hurry to raise interest rates. The U.S. central bank also, as expected,...

    Amgen's stock soars to record high on news of planned job cuts

    Amgen's stock soars to record high on news of planned job cuts
    Amgen shares jumped to an all-time high Wednesday morning, a day after the biotech giant announced a restructuring plan that includes up to 2,900 job cuts. Investors welcomed the move. At one point, Amgen's stock reached a record high of $131.24, before...

    Amgen to cut 2,900 workers and close four facilities

    Biotech giant Amgen Inc. said it would cut up to 2,900 employees and close facilities in Washington state and Colorado as the Thousand Oaks company moved to rein in costs and focus on new drugs. The company said the cuts, which would hit nearly 15% of...